Skip to content
CancerIndex

Publication

Feasibility of blinatumomab in newly diagnosed pediatric B-cell acute lymphoblastic leukemia patients requiring modification of standard chemotherapy.

Wenjuan Wang, Hailing Liu, Yingjie Chen, Jincheng Wang, Xiaohui Zhang, Tingjie Wang, Guangbo Tang, Pengchuang Zhang, Moyin Zhang, Peng Gao, Zihang Li

Leukemia researchOct 1, 2026PMID 42561551doi:10.1016/j.leukres.2026.108288 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Oct 1, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20261001-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

PURPOSE: Newly diagnosed pediatric B-cell acute lymphoblastic leukemia (B-ALL) patients who require modification of standard chemotherapy because of severe treatment-related toxicities or inadequate early response represent an understudied population with limited therapeutic evidence. We evaluated…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.